Monogenic Obesity

POMC deficiency

Proopiomelanocortin (POMC) deficiency is often caused by biallelic variants in the POMC gene1

100-500 people living with POMC deficiency

There are approximately 100-500 people living with POMC deficiency in the United States2

The POMC gene encodes for the POMC protein3:

  • POMC is processed by the serine endoprotease, prohormone convertase 1/3 (PC1/3), encoded by the PCSK1 gene
  • POMC is proteolytically cleaved to form Alpha-melanocyte stimulating hormone (α-MSH), which activates melanocortin-4 receptor (MC4R) downstream in the pathway

Get connected. Find resources and get more information

Signs and symptoms of POMC deficiency4-8

  • Hyperphagia
  • Obesity
  • Hypoglycemia
  • Hypothyroidism
  • Adrenocorticotropic hormone (ACTH) deficiency
  • Hypogonadotropic hypogonadism
  • Red hair and light skin pigmentation
  • Liver disease

Two key features among a wide range of symptoms4,5:

Plate with fork and knife to represent hunger icon

HyperphagiaChronic pathological condition characterized by insatiable hunger, impaired satiety, and persistent abnormal food-seeking behaviors

Scale icon

Early-onset obesityEarly-onset, severe obesity by age 1

MUST EAT NOW brain image
Every 5 minutes, he asked for food, or referenced food, or went to the kitchen to find food. I was swimming in the dark, not knowing what to do.”

– Caregiver of a child living with POMC deficiency

Genetic inheritance

POMC deficiency is inherited in an autosomal recessive manner.1

Individuals can have biallelic or heterozygous variants of POMC. Variants may be identified through genetic testing. Individuals with heterozygous POMC variants may experience POMC insufficiency and develop some symptoms of POMC deficiency, such as hyperphagia and obesity.3,7,9,10

Heterozygous variants of POMC

Heterozygous variants of POMC are found more frequently in people with obesity than in normal-weight individuals.

Homozygous variants of POMC

Unlike the homozygous disease (POMC deficiency), individuals who are heterozygous for POMC may not exhibit endocrine abnormalities.

Diagnosis

These conditions may be difficult to diagnose based solely on clinical manifestations, but genetic testing may be helpful.

Uncovering Rare Obesity icon

Genetic testing through the Uncovering Rare Obesity® program is available for eligible patients.

Visit UncoveringRareObesity.com

Karen and Nate’s Story video

Watch how Karen and her son Nate, who lives with POMC deficiency, coped through finding a diagnosis.

Find out about a treatment option for obesity due to POMC deficiency.

Father and daughter hugging. Actor portrayals.

Personalized one-on-one educational support* for your patients living with POMC deficiency

Rhythm InTune provides educational resources, wellness tips, and connection to a community for people living with POMC deficiency

Patient Education Managers are employees of Rhythm Pharmaceuticals and do not provide medical care or advice. We encourage patients to always speak to their healthcare providers regarding their medical care.

References
  1. National Institutes of Health. Bardet-Biedl syndrome. MedlinePlus. Updated August 18, 2020. Accessed April 1, 2025. https://medlineplus.gov/genetics/condition/bardet-biedl-syndrome/#inheritance
  2. Data on file. Rhythm Pharmaceuticals, Inc. Boston, MA.
  3. Stijnen P, Ramos-Molina B, O'Rahilly S, Creemers JW. PCSK1 mutations and human endocrinopathies: from obesity to gastrointestinal disorders. Endocr Rev. 2016;37(4):347-371. doi:10.1210/er.2015-1117
  4. Eneli I, Xu J, Webster M, et al. Tracing the effect of the melanocortin-4 receptor pathway in obesity: study design and methodology of the TEMPO registry. Appl Clin Genet. 2019 Jun 5;12:87-93. doi:10.2147/TACG.S199092
  5. Huvenne H, Dubern B, Clément K, Poitou C. Rare genetic forms of obesity: clinical approach and current treatments in 2016. Obes Facts. 2016;9(3):158-173. doi:10.1159/000445061
  6. Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity–assessment, treatment, and prevention: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(3):709-757. doi:10.1210/jc.2016-2573
  7. Courbage S, Poitou C, Le Beyec-Le Bihan J, et al. Implication of heterozygous variants in genes of the leptin-melanocortin pathway in severe obesity. J Clin Endocrinol Metab. 2021;106(10):2991-3006. doi:10.1210/clinem/dgab404
  8. National Organization for Rare Disorders. POMC deficiency. NORD. Updated March 6, 2023. Accessed April 1, 2025. https://rarediseases.org/rare-diseases/pomc-deficiency
  9. Coll AP, Farooqi IS, Challis BG, Yeo GS, O'Rahilly S. Proopiomelanocortin and energy balance: insights from human and murine genetics. J Clin Endocrinol Metab. 2004;89(6):2557-2562. doi:10.1210/jc.2004-0428
  10. Mendiratta MS, Yang Y, Balazs AE, et al. Early onset obesity and adrenal insufficiency associated with a homozygous POMC mutation. Int J Pediatr Endocrinol. 2011;2011(1):5. doi:10.1186/1687-9856-2011-5